Ligand Acquires Rights to More Than 15 Fully-Funded Development Programs from Selexis SA May 11, 2015
Ligand to Present Results of LGD-6972 Phase 1b Trial at American Diabetes Association 75th Scientific Sessions on June 7th and Host Investor Presentation May 7, 2015
Ligand Partner TG Therapeutics Presents Positive Pre-clinical Data on IRAK4 Compounds at the American Association for Cancer Research (AACR) Annual Meeting April 20, 2015
